Effect of systemic bevacizumab in severe hereditary hemorrhagic telangiectasia associated with bleeding. Am J Hematol 2016 Jun;91(6):E313-4
Date
03/20/2016Pubmed ID
26994402DOI
10.1002/ajh.24367Scopus ID
2-s2.0-84966440683 (requires institutional sign-in at Scopus site) 21 CitationsAuthor List
Epperla N, Kapke JT, Karafin M, Friedman KD, Foy PAuthor
Kenneth D. Friedman MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAntineoplastic Agents, Immunological
Bevacizumab
Female
Hemorrhage
Humans
Male
Middle Aged
Telangiectasia, Hereditary Hemorrhagic
